Clinical trial
Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate…
NCT00167648 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00167648 |
|---|---|
| Title | Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer |
| Official title | Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer |
| Acronym | NE2 |
| Lead sponsor | University of Washington, Other |
| Collaborators | Pacific Northwest SPORE |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer, Prostate Neoplasms |
| Intervention type | Drug |
| Interventions | Leuprolide or goserelin, Transdermal estradiol |
| Enrollment | 17 |
| Start date | Mar 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 19, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: